<?xml version="1.0" encoding="utf-8"?><svg:svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:svg="http://www.w3.org/2000/svg" version="1.1" width="595.22px" height="842px" preserveAspectRatio="none" viewBox="0 0 595.22 842"><svg:defs><svg:clipPath id="--clippath0" transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:clipPath><svg:style type="text/css">@font-face { font-family: "g_d0_f1";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f2";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f3";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f4";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f5";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f6";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f7";; src: url(data:font/woff;base64,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); } </svg:style></svg:defs><svg:g transform="matrix(1 0 0 -1 0 842)"><svg:g transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:g><svg:g clip-path="url(#clippath0)"><svg:g transform=""><svg:text transform="matrix(11 0 0 11 389.531 779.9031) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.577 1.063 1.401 2.098 2.584 3.018 3.577 3.747 4.264 4.758 4.964 5.45 5.602 5.952 6.474 6.994 7.308 7.646 7.828 8.262 8.444 8.961 9.483 9.833 10.345 10.695 11.2 11.382 11.904 12.218 12.74 13.054 13.236 13.67" font-family="g_d0_f1" font-size="1px" fill="rgb(43,46,52)">Farmacología, nutrición y dietética</svg:tspan></svg:text><svg:text transform="matrix(7.5 0 0 7.5 536.703 52.9521) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.556 1.112" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)">279</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 87.226 761.2006) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.631 0.993 1.209 1.757 2.196 2.412 2.951 3.167 3.711 4.09 4.602 5.041 5.379 5.595 6.092 6.636 6.821 7.2 7.712 8.05 8.598 9.146 9.69 9.902 10.446" font-family="g_d0_f3" font-size="1px" fill="rgb(64,198,192)">Principio activo: atenolol</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.6094 744.7964) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.778 1.278 1.722 1.9213 2.4213 2.9213 3.1206 3.6206 4.1206 4.8426 5.0646 5.5646 5.7866 6.2306 6.5086 6.8416 7.3416 7.8416 8.0636 8.5636" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Vías de administración</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.649 744.8818) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.212 0.646 0.914 1.182 1.616 1.995 2.429 2.863 3.297 3.676 4.11 4.322 4.534 4.968 5.236 5.67" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Intravenosa, oral</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.6094 727.0795) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.555 1.777 2.221 2.443 2.943 3.443 3.943 4.165 4.443 4.943 5.443 5.665 6.165" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Dosis habituales</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.649 727.1655) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 1.333 1.777 1.999 2.388 2.61 3.054 3.276 3.498 3.942 4.22 4.498 4.942 5.331 5.775 6.219 6.663 7.052 7.496 7.718 7.94 8.384 8.606 8.995 9.217 9.661 9.883 10.327 10.716 10.938 11.16 11.716 11.938 12.16 12.604 12.993 13.215 13.659 13.881 14.548 14.77 15.214 15.658 15.936 16.38 16.769 16.991 17.269 17.713 18.157 18.601 18.879 19.101 19.379 19.601 20.045 20.489 20.878 21.1 21.489 21.711 21.933 22.377 22.655 23.099 23.321 23.765 24.209 24.487 24.931 25.32 25.542 25.986 26.43 26.819 27.263 27.707 28.151 28.54 28.762 29.151 29.595 30.039 30.317 30.539 30.983 31.427 31.871 32.149 32.371 32.76 33.204 33.648 33.87 34.259 34.481 34.925 35.147 35.591 35.869 36.313 36.535 36.757 37.201 37.645 37.923 38.367 38.811 39.255" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">5 mg vía intravenosa iniciales. A los 5 minutos repetir dosis. 1-2 horas después continuar con vía oral 50-100 </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.649 716.9655) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.667 1.111 1.444 1.888 2.11" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">mg/día</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.6094 700.7765) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.278 1.5 2 2.5 3 3.222 3.722 4.222 4.722" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Indicaciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.649 700.8615) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.212 0.758 1.526 1.738 2.117 2.551 2.985 3.197 3.631 3.843 4.277 4.656 5.09 5.469 5.681 6.115 6.549 6.761 7.251 7.595 7.807 8.019 8.398 8.61 9.044 9.478 9.746 10.18 10.837 11.271 11.483 11.917 12.351 12.619 12.887 13.099 13.478 13.912 14.124 14.558 14.992 15.426 15.86 16.294 16.506 16.718 17.152 17.586 18.02 18.232 18.666 19.1 19.312 19.746 20.125 20.393 20.827 21.261 21.473 21.907 22.119 22.331 22.765 22.977 23.411 23.845 24.279 24.713 25.092 25.304 25.738 26.006 26.274 26.486 26.754 27.411 27.623 28.057 28.436 28.648 29.027 29.461 29.729 30.163 30.375 30.809 31.188 31.622 32.001 32.213 32.425 32.859 33.071 33.505 33.939 34.207 34.475 34.909 35.343 35.722 35.934 36.368 36.802 37.014 37.448 37.716 37.984 38.418 38.686 38.898 39.332" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">IAM con elevación ST, síndrome aórtico agudo, angina estable, algunas arritmias cardiacas, hipertensión arterial</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.6094 685.9916) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.611 1.833 2.333" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Acción</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.649 685.3466) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">β</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 180.9738 686.0776) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722 0.944 1.388 1.832 2.276 2.72 3.164 3.608 3.886 4.33 4.552 4.941 5.385 5.607 6.051 6.44 6.718 6.94 7.329 7.773" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">-bloqueante selectivo </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 248.92875 685.3466) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">β</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 253.2527 686.0776) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 0.888 1.277 1.721 1.943 2.332 2.776 2.998 3.442 3.831 4.109 4.331 4.72 4.942 5.386 5.83 6.274 6.496 6.94 7.162 7.551 8.218 8.44 8.884 9.328 9.717 10.161 10.383 10.772 11.216 11.66 11.882 12.326 12.548 12.77 13.214 13.658 14.325 14.769 15.213 15.491 15.935 16.157 16.601 17.045 17.267 17.489 17.933 18.155 18.599 19.043 19.432 19.654 20.043 20.265 20.487 20.931 21.209 21.653 22.042 22.32 22.764 22.986 23.208 23.652 24.096 24.374 24.652 25.096 25.54 25.762 26.151 26.595 26.817 27.261 27.705 28.149 28.593 28.871 29.093 29.482" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">1. La selectividad disminuye con el aumento de la dosis. Efecto inotrópico negativo</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.6094 668.7875) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.778 1.278 1.778 2.056 2.556 3 3.222 3.666 4.166 4.666 5.166 5.666 6.166 6.666 6.999 7.221 7.721" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Efectos secundarios</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.649 668.8725) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.722 1.166 1.61 2.054 2.498 2.942 3.164 3.72 3.998 4.398 4.62 4.842 5.286 5.564 6.008 6.452 6.674 7.063 7.507 7.785 8.229 8.451 8.895 9.117 9.339 9.783 10.005 10.449 10.893 11.171 11.615 12.059 12.448 12.67 13.114 13.558 13.78 14.002 14.391 14.613 15.057 15.501 15.945 16.167 16.556 17 17.389 17.611 18.055 18.499 18.721 18.943 19.387 19.665 20.109 20.387 21.054 21.276 21.554 21.998 22.442 22.72 23.164 23.386 23.83 24.274 24.496 24.94 25.384 25.773 25.995 26.439 26.883 27.161 27.605 27.994 28.216 28.605 29.049 29.493 29.715 30.159 30.437 30.715 31.159 31.437 31.659 32.103 32.547 32.991 33.269 33.491 33.935 34.157 34.601 35.045 35.323 35.545 35.823 36.267 36.545 36.767 37.156 37.6 37.822" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Bloqueo A-V, bradicardia, hipotensión, claudicación intermitente en pacientes con arteriopatía periférica, </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.649 658.6725) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.055 1.499 1.721 1.943 2.332 2.554 2.998 3.442 3.831 4.053 4.497 4.719 5.108 5.552 5.83 6.274 6.496 6.94 7.329 7.773 7.995 8.217 8.661 9.105 9.549 9.938 10.382 10.826 11.215 11.437 11.659 12.048 12.492 13.159 13.381 13.659 14.103 14.492 14.714 14.936 15.38 15.602 16.046 16.324 16.602 17.046 17.49 17.712 17.934 18.378 18.656 19.1 19.544 19.933 20.377 20.821 21.21 21.654 22.098 22.487 23.154 23.598 23.82 24.042 24.486 24.708 25.097 25.541 25.985 26.429 26.651 26.873 27.317 27.539 27.983 28.427 28.871 29.093 29.537 29.926 30.37 31.037 31.259" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">insuﬁ ciencia cardiaca, náuseas, vómitos, diarrea, broncoespasmo, disnea, hipoglucemia</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.6094 642.1415) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.056 1.556 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Interacciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.649 642.2275) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.278 1.722 2.166 2.61 2.832 3.054 3.498 3.942 4.164 4.386 4.942 5.386 5.83 6.219 6.497 6.941 7.33 7.552 7.941 8.385 8.774 8.996 9.218 9.662 9.884 10.328 10.772 10.994 11.272 11.494 11.938 12.16 12.382 12.826 13.27 13.714 14.103 14.547 14.991 15.435 15.879 16.101 16.323 16.545 16.989 17.433 17.711 18.155 18.599 18.988 19.21 19.654 19.876 20.32 20.598 21.042 21.431 21.709 22.153 22.542 22.764 23.208 23.652 23.93 24.152 24.596 24.818 25.262 25.706 25.984 26.262 26.706 27.15 27.539 27.983 28.261 28.705 29.094 29.316 29.705 29.927 30.371 30.815 31.093 31.315 31.759 32.037 32.315 32.537 32.815 33.482 33.704 34.093 34.537 34.926 35.148 35.37 35.814 36.258 36.536 36.98 37.202 37.591 38.035 38.479" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Adrenalina. Anestésicos (elegir el adecuado). Potencia efectos antihipertensores y antiarrítmicos junto con </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.649 632.0275) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722 1 1.667 2.111 2.5 2.944 3.333 3.555 3.999 4.221 4.665 5.109 5.387 5.831 6.275 6.664 7.108 7.386 7.83 8.219 8.441 8.83 9.274 9.941 10.385 10.607 11.051 11.718 11.94 12.384 12.828 13.272 13.55 13.994 14.438 14.882 15.104 15.326 15.77 15.992 16.214 16.492 16.714 17.158 17.491 17.935 18.602 18.824 19.046 19.435 19.879 20.157 20.601 21.045 21.489 22.156 22.378 22.6 23.044 23.266 23.488 23.932 24.21 24.599" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">fármacos hipotensores como amiodarona, diltiazem, verapamilo, etc.</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.609052 616.3042) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.889 1.389 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111 5.555" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Precauciones </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.609052 606.104199) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.944 1.444 1.944 2.444 2.666 3.166 3.388 3.888" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">especiales</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.649 616.389199) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.722 0.944 1.388 1.721 2.388 2.832 3.11 3.554 3.776 3.998 4.22 4.664 5.108 5.552 5.996 6.44 6.662 7.106 7.55 8.217 8.661 9.05 9.439 9.883 10.161 10.605 10.883 11.105 11.383 11.605 11.883 12.327 12.605 13.049 13.438 13.66 14.049 14.493 14.882 15.104 15.493 15.715 15.937 16.381 16.825 17.269 17.713 18.157 18.379 19.046 19.49 19.934 20.156 20.378 20.6 20.989 21.433 21.711 21.933 22.155 22.599 22.821 23.099 23.543 23.987 24.431 24.653 25.042 25.486 25.764 26.208 26.43 26.874 27.096 27.54 27.984 28.206 28.428 28.872 29.094 29.538 29.76 30.204 30.648 31.092 31.314 31.758 32.147 32.591 33.258 33.48" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Prinzmetal. Puede enmascarar tirotoxicosis. Puede modiﬁ car la taquicardia de la hipoglucemia</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 87.5284 573.547) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.631 0.993 1.209 1.757 2.196 2.412 2.951 3.167 3.711 4.09 4.602 5.041 5.379 5.595 6.092 6.636 6.821 7.2 7.748 8.288 9.013 9.557 9.769 10.313 10.525" font-family="g_d0_f3" font-size="1px" fill="rgb(64,198,192)">Principio activo: esmolol </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.1748 557.1425) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.778 1.278 1.722 1.9213 2.4213 2.9213 3.1206 3.6206 4.1206 4.8426 5.0646 5.5646 5.7866 6.2306 6.5086 6.8416 7.3416 7.8416 8.0636 8.5636" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Vías de administración</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.214 557.2285) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.212 0.646 0.914 1.182 1.616 1.995 2.429 2.863 3.297 3.676 4.11 4.322 4.534 4.968 5.236 5.67" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Intravenosa, oral</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.1748 539.4265) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.555 1.777 2.221 2.443 2.943 3.443 3.943 4.165 4.443 4.943 5.443 5.665 6.165" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Dosis habituales</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.214 539.5115) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.166 1.61 1.832 2.054 2.498 2.72 3.109 3.331 3.775 3.997 4.219 4.441 4.885 5.329 5.607 6.051 6.273 6.717 7.161 7.383 7.827 8.049 8.493 8.715 9.382 9.826 10.048 10.27 10.714 11.158 11.38 11.824 12.102 12.546 12.768 13.435 13.657 14.101 14.545 14.823 15.267 15.656 15.878 16.1 16.322 16.822 17.266 17.71 17.988 18.21 18.654 19.098 19.542 19.82 20.042 20.431 20.875 21.319 21.541 21.985 22.429 22.873 23.095 23.539 23.983 24.261 24.539 24.983 25.372 25.594 26.038 26.482 26.704 27.148 27.37 27.814 28.036 28.48 28.702 29.369 29.813 30.146 30.535 30.979 31.312 31.979 32.201 32.645 33.089 33.367 33.811 34.033" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Bolo inicial lento de 0,5 mg (en 2-5 minutos). Continuar con una perfusión a 0,1 mg/kg/minuto, </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.214 529.3115) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.055 1.333 1.777 2.444 2.888 3.332 3.61 4.054 4.498 4.942 5.386 5.608 6.052 6.274 6.718 6.94 7.384 7.828 8.05 8.717 9.161 9.494 9.716 10.105 10.549 10.882 11.549 11.771 12.215 12.659 12.937 13.381 13.603 13.992 14.436 14.88 15.324 15.546 15.99 16.434 16.712 17.156 17.6 17.822 18.489 18.711 19.155 19.599 19.877 20.321 20.71 20.932 21.154 21.543 21.765 22.209 22.876 23.32 23.598 24.042 24.264 24.653 24.875 25.264 25.708 26.152 26.596 27.04 27.484 27.706 27.928 28.372 28.594 29.038 29.482 29.76 30.427 30.649 30.927 31.371 31.593 31.815 32.259 32.481 32.925 33.203 33.647 34.036 34.258 34.702 35.146 35.368 35.812 36.09 36.368 36.812 37.09 37.312 37.756 37.978 38.2" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">incrementándola 0,05 mg/ kg/minuto cada 10-15 minutos, siempre y cuando lo permita la presión arterial, </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.214 519.1115) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.277 1.555 1.999 2.221 2.61 3.054 3.498 3.887 4.331 4.775 5.219 5.441 5.719 5.941 6.219 6.663 7.052 7.496 7.94 8.384 8.773 9.051 9.495 9.717 9.995 10.439 10.717 11.161 11.605 12.049 12.493 12.771 12.993 13.382 13.826 14.048 14.492 14.714 15.158 15.38 15.769 16.213 16.657 16.99 17.434 17.712 17.934 18.378 18.822 19.211 19.433 19.822 20.044 20.488 20.932 21.154 21.598 21.82 22.264 22.486 23.153 23.597 23.93 24.319 24.763 25.096 25.763 25.985 26.429 26.873 27.151" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">hasta conseguir respuesta terapéutica o alcanzar dosis de 0,3 mg/kg/minuto</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.1748 502.6415) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.278 1.5 2 2.5 3 3.222 3.722 4.222 4.722" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Indicaciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.214 502.7265) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.36 0.794 1.228 1.662 1.874 2.253 2.687 2.955 3.389 3.601 4.035 4.2482 4.6272 5.0612 5.4952 5.7632 6.1972 6.5762 7.0102 7.4442 7.7122 7.9802 8.1922 8.5712 9.0052 9.2172 9.6512 9.8492 10.0612 10.2744 10.4914 10.7046 11.1386 11.4066 11.6746 12.1086 12.3766 12.5898 13.0238 13.4578 13.7258 13.9378 14.3168 14.7508 14.9628 15.3968 15.5948 15.8068 16.02 16.237 16.4502 16.8842 17.1522 17.3642 17.5762 18.0102 18.3892 18.6012 19.0352 19.4692 19.6824 20.1164 20.5504 20.8184 21.0304 21.4094 21.8434 22.0554 22.4894 22.6874 22.8994 23.1126 23.3246 23.7036 24.1376 24.5716 25.0056 25.6626 25.8746 26.3086 26.5218 27.1788 27.3908 27.8248 28.2038 28.6378 28.9058 29.3398 29.5518 29.9308" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Taquicardia supraventricular, ﬂ utter auricular, ﬁ brilación auricular, isquemia miocárdica</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.1748 487.8565) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.611 1.833 2.333" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Acción</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.214 487.9415) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.722 1.166 1.61 2.054 2.498 2.942 3.164 3.608 4.052 4.33 4.774 5.218 5.662 5.94 6.384 6.606 6.995" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Bloqueo adrenérgico</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 239.443799 487.2105) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 241.568799 487.2105) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">β</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 245.892749 487.9415) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 1.055 1.499 1.721 2.165 2.554 2.832 3.054 3.443" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">1 selectivo</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.1748 470.6525) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.778 1.278 1.778 2.056 2.556 3 3.222 3.666 4.166 4.666 5.166 5.666 6.166 6.666 6.999 7.221 7.721" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Efectos secundarios</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.214 470.7375) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.778 1.222 1.666 2.055 2.499 2.943 3.332 3.776 4.22 4.609 5.276 5.72 5.942 6.164 6.608 6.83 7.274 7.718 7.996 8.44 8.884 9.273 9.495 9.939 10.383 10.605 10.827 11.049 11.493 11.882 12.326 12.548 12.77 13.159 13.381 13.825 14.269 14.658 14.88 15.324 15.546 15.935 16.379 16.657 17.101 17.323 17.767 18.156 18.6 18.822 19.044 19.433 19.877 20.155 20.433 20.655 21.099 21.543 21.765 21.987 22.376 22.82 23.487 23.931 24.375 24.597 25.041 25.485 25.874 26.096 26.54 26.762 26.984 27.428 27.872 28.316 28.705 29.149 29.593 29.982 30.204 30.426 30.815 31.259 31.926 32.148 32.426 32.87 33.259 33.481 33.703 33.925 34.147 34.591 35.035 35.257 35.535 35.757" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Broncoespasmo, hipotensión, insuﬁ ciencia cardiaca, vértigo, somnolencia, náuseas, vómitos, ﬂ ebitis</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.1748 452.7645) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.056 1.556 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Interacciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.214 452.8495) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.444 1.888 2.555 2.777 3.221 3.665 3.887 4.109 4.553 4.997 5.275 5.719 6.163 6.607 6.829 7.051 7.495 7.939 8.161 8.383 8.827 9.049 9.493 9.937 10.326 10.548 10.992 11.436 11.658 11.88 12.269 12.713 13.102 13.491 13.713 14.157 14.379 14.601 14.99 15.434 15.656 15.878 16.322" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Dopamina, adrenalina, digoxina, succinilcolina</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.174904 434.925549) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.889 1.389 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111 5.555" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Precauciones </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.174904 424.725549) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.944 1.444 1.944 2.444 2.666 3.166 3.388 3.888" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">especiales</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.214 435.011399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.11 1.554 1.998 2.387 2.609 3.053 3.497 3.775 4.219 4.608 4.83 5.219 5.663 6.107 6.329 6.773 6.995 7.384 8.051 8.273 8.717 9.161 9.55 9.772 10.216 10.66 10.882 11.326 11.77 11.992 12.214 12.658 12.88 13.158 13.602 14.046 14.435 14.657 15.101 15.545 15.767 16.156 16.6 16.878 17.322 17.544 17.988 18.377 18.821 19.043 19.265 19.821 20.21 20.877" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">En pacientes con disminución de la función cardiaca. Asma</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.8362 374.3085) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.778 1.278 1.722 1.9213 2.4213 2.9213 3.1206 3.6206 4.1206 4.8426 5.0646 5.5646 5.7866 6.2306 6.5086 6.8416 7.3416 7.8416 8.0636 8.5636" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Vías de administración</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.876 374.3935) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.212 0.646 0.914 1.182 1.616 1.995 2.429 2.863 3.297 3.676 4.11 4.322 4.534 4.968 5.236 5.67" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Intravenosa, oral</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.8362 356.5915) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.555 1.777 2.221 2.443 2.943 3.443 3.943 4.165 4.443 4.943 5.443 5.665 6.165" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Dosis habituales</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.876 356.6765) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 1.333 1.777 1.999 2.221 2.665 2.943 3.221 3.665 4.054 4.498 4.942 5.386 5.775 6.219 6.441 6.663 6.885 7.329 7.773 8.051 8.495 8.717 8.939 9.383 9.827 10.049 10.493 10.771 11.215 11.437 12.104 12.326 12.77 13.214 13.492 13.936 14.325 14.547 14.769 14.991 15.491 15.935 16.379 16.823 17.101 17.323 17.601 17.823 18.212 18.656 19.1 19.544 19.766 20.21 20.432 21.099 21.321 21.765 22.209 22.487 22.931 23.32 23.542 23.986 24.43 24.819 25.097 25.541 25.763 26.207 26.651 27.095 27.317 27.761 28.205 28.594 28.816 29.205 29.427 29.705 30.149 30.427 30.871 31.093 31.315 31.759 32.203 32.425 32.869 33.313 33.535 34.202 34.646 34.868 35.09 35.59 35.812 36.034 36.478 36.7" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">5 mg intravenosa (lento, de 1-2 minutos). Repetir cada 5 minutos hasta una dosis total de 15 mg. Si el </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.876 346.4765) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.277 1.499 1.943 2.387 2.665 3.109 3.331 3.775 4.219 4.441 4.719 5.163 5.385 5.829 6.107 6.551 6.995 7.439 7.661 8.105 8.327 8.771 9.215 9.437 9.659 10.103 10.492 10.714 11.158 11.602 11.824 12.491 12.935 13.157 13.601 14.045 14.323 14.545 14.934 15.156 15.6 15.822 16.044 16.488 16.766 17.044 17.488 17.877 18.321 18.765 19.209 19.598 20.042 20.264 20.486 20.93 21.374 21.818 22.262 22.706 22.928 23.317 23.761 24.428 24.872 25.316 25.649 26.093 26.371 26.76 27.204 27.426 27.815 28.259 28.703 28.925 29.147 29.591 29.813 30.202 30.424 30.868 31.09 31.534 31.812 32.256 32.478 32.7 33.144 33.588 33.81 34.477 34.699 35.143 35.587 35.865 36.309 36.698" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">paciente ha tolerado bien los 15 mg por vía intravenosa, puede comenzarse con la vía oral 15 minutos </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.876 336.2765) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.277 1.721 2.165 2.609 2.998 3.22 3.664 4.108 4.33 4.552 4.996 5.218 5.662 5.884 6.162 6.384 7.051 7.495 7.717 8.161 8.605 8.994 9.216 9.605 9.827 10.049 10.493 10.771 11.049 11.493 11.882 12.326 12.77 13.214 13.603 14.047 14.269 14.491 14.88 15.324 15.768 15.99 16.434 16.878 17.156 17.6 18.044 18.266 18.933 19.377 19.71 20.099 20.321 20.765 20.987 21.431 21.709 22.153 22.375 22.708 23.152 23.374 23.818 24.04 24.484 24.928 25.206 25.65 26.094 26.372 26.816 27.038 27.482 27.926 28.148 28.592 29.036 29.314 29.758 30.147 30.369 30.758 30.98 31.424 31.868 32.257 32.701 33.145 33.589 33.978 34.2 34.589 35.033 35.477 35.921 36.143 36.421 36.643 37.032 37.476 37.92 38.142 38.364 38.808" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">después de la última dosis intravenosa, con 25-50 mg/vía oral/6 h durante 48 horas y después seguir con la </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.876 326.077349) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.277 1.499 1.888 2.11 2.554 2.998 3.22 3.887 4.331 4.775 5.053 5.497 5.941 6.163 6.83 7.052 7.496 7.94 8.218 8.662 8.884 9.328 9.772 9.994 10.438 10.882 11.326 11.548 12.215 12.659 12.992 13.436 13.714 14.158 14.38 14.713 15.157 15.601 15.823" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">dosis de mantenimiento de 100 mg/oral/12 h</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.8362 308.7175) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.278 1.5 2 2.5 3 3.222 3.722 4.222 4.722" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Indicaciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.876 308.8026) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.546 0.814 1.082 1.294 1.562 2.219 2.431 2.865 3.244 3.456 3.835 4.269 4.703 4.971 5.405 5.784 6.218 6.652 6.92 7.188 7.4 7.779 8.213 8.425 8.859 9.127 9.561 9.94 10.152 10.364 10.798 11.232 11.666 11.878 12.312 12.746 12.958 13.392 13.826 14.038 14.472 14.906 15.285 15.719 16.153 16.365 16.577 16.789 17.335 18.103 18.315 18.527 18.961 19.173 19.607 20.041 20.309 20.577 21.011 21.445 21.824 22.036 22.47 22.904 23.116 23.55 23.818 24.086 24.52 24.788 25 25.434" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Arritmias supraventriculares, angina de pecho, IAM, hipertensión arterial</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.8362 293.9325) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.611 1.833 2.333" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Acción</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.876 294.0175) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.722 1.166 1.61 2.054 2.498 2.942 3.164 3.608 4.052 4.33 4.774 5.218 5.662 5.94 6.384 6.606 6.995" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Bloqueo adrenérgico</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 240.104952 293.2865) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 242.229952 293.2865) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">β</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 246.554752 294.0175) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 1.055 1.499 1.721 2.165 2.554 2.832 3.054 3.443" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">1 selectivo</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.8362 276.7285) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.778 1.278 1.778 2.056 2.556 3 3.222 3.666 4.166 4.666 5.166 5.666 6.166 6.666 6.999 7.221 7.721" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Efectos secundarios</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.876 276.8135) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.111 1.333 1.777 2.221 2.443 2.665 3.332 3.776 4.054 4.498 4.942 5.331 5.553 5.775 6.164 6.608 6.886 7.33 7.552 7.996 8.44 8.829 9.051 9.273 9.773 10.217 10.495 10.939 11.606 12.05 12.494 12.772 13.216 13.438 13.66 14.104 14.493 14.937 15.159 15.381 15.77 15.992 16.436 16.88 17.269 17.491 17.935 18.157 18.546 18.99 19.268 19.712 19.934 20.378 20.767 21.211 21.433 21.655 22.099 22.543 22.765 23.209 23.431 23.709 24.153 24.542 24.764 25.208 25.652 26.096 26.485 26.707 26.929 27.373 27.651 27.929 28.151 28.429 29.096 29.318 29.762 30.151 30.373 30.595 30.873 31.317 31.761 32.205 32.872 33.316 33.76 34.204 34.426 34.87 35.314 35.536 36.036 36.48 36.869 37.313 37.757 38.201 38.645 38.867" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Fatiga, mareos, cefaleas. Raramente insuﬁ ciencia cardiaca, palpitaciones, arritmias, fenómeno de Raynaud, </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.876 266.6135) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.332 1.999 2.443 2.665 2.887 3.331 3.775 3.997 4.441 4.719 4.941 5.385 5.663 6.107 6.496 6.94 7.218 7.662 7.884 8.328" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">edema, dolor precordial</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.8362 250.0505) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.056 1.556 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Interacciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.876 250.1355) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.444 1.833 2.111 2.555 2.944 3.166 3.555 3.999 4.388 4.61 4.832 5.11 5.332 5.61 6.054 6.721 7.165 7.387 7.776 7.998 8.442 8.886 9.108 9.33 9.719 9.941 10.608 11.052 11.33 11.552 11.996 12.218 12.662 13.106 13.328 13.55 13.994 14.272 14.55 14.994 15.383" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Anestésicos, rifampicina, cimetidina, otros </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 309.514248 249.4045) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">β</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 313.838199 250.1355) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722 0.944 1.388 1.832 2.276 2.72 3.164 3.608 3.886 4.33 4.719 4.941 5.163 5.607 6.051 6.329 6.773 7.217 7.661 7.883 8.105 8.549" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">-bloqueantes, adrenalina</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.836041 232.211549) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.889 1.389 1.889 2.389 2.889 3.389 3.611 4.111 4.611 5.111 5.555" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Precauciones </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 91.836041 222.011549) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.5 0.944 1.444 1.944 2.444 2.666 3.166 3.388 3.888" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">especiales</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 176.875989 232.296549) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.945 1.612 2.056 2.278 2.5 2.889 3.111 3.389 3.833 4.277 4.499 4.943 5.165 5.832 6.276 6.665 7.109 7.317 7.539 7.761 8.205 8.427 8.871 9.315 9.759 10.037 10.481 10.87 11.092 11.759 12.203 12.425 12.647 12.869 13.147 13.591 13.98 14.202 14.424 14.868 15.312 15.701 16.145 16.423 16.867 17.311 17.755 17.977 18.255 18.477 18.755 19.199 19.421 19.865 20.309" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Asma, cirugía mayor, diabetes mellitus, desorden tiroideo</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 87.8118 390.712) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.631 0.993 1.209 1.757 2.196 2.412 2.951 3.167 3.711 4.09 4.602 5.041 5.379 5.595 6.092 6.636 6.821 7.2 7.925 8.473 8.811 9.355 9.894 10.247 10.791 11.003 11.547" font-family="g_d0_f3" font-size="1px" fill="rgb(64,198,192)">Principio activo: metoprolol</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 95.2566 168.1215) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 0.778 1.278 1.722 1.9213 2.4213 2.9213 3.1206 3.6206 4.1206 4.8426 5.0646 5.5646 5.7866 6.2306 6.5086 6.8416 7.3416 7.8416 8.0636 8.5636" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Vías de administración</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 180.296 168.2065) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.212 0.646 0.914 1.182 1.616 1.995 2.429 2.863 3.297 3.676 4.11 4.322 4.534 4.968 5.236 5.67" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Intravenosa, oral</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 95.2566 150.4055) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.555 1.777 2.221 2.443 2.943 3.443 3.943 4.165 4.443 4.943 5.443 5.665 6.165" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Dosis habituales</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 180.296 150.4905) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 1.333 1.777 2.11 2.777 2.999 3.443 3.887 4.165 4.609 4.831 5.275 5.719 6.108 6.386 6.83 7.052 7.496 7.94 8.162 8.829" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">1 mg/minuto hasta 10 mg</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 95.2566 134.8145) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.278 0.778 1.278 1.5 2 2.5 3 3.222 3.722 4.222 4.722" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Indicaciones</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 180.296 134.8995) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.778 1.222 1.666 1.944 2.222 2.666 3.11 3.499 3.721 4.165 4.609 4.831 5.275 5.553 5.831 6.275 6.553 6.775 7.219 7.441 7.663 7.885 8.329 8.773 9.217 9.661 9.869 10.091 10.313 10.757 11.035 11.479 11.701 11.923 12.145 12.589 12.978 13.2 13.589 13.811 14.255 14.477 14.699 15.143 15.421 15.865 16.309 16.531 16.975 17.197 17.641 17.974 18.418 18.64 18.918 19.196 19.64 20.029 20.251 20.473 21.029 21.807 22.029 22.251 22.695 22.973 23.251 23.473 23.751 24.418 24.64 25.084 25.473 25.695 26.084 26.528 26.972 27.25 27.694 28.083 28.527 28.971 29.249 29.527 29.749 30.138 30.582 30.804 31.248 31.526 31.97 32.359 32.581 32.803 33.081 33.525 33.969 34.413 34.635 35.024 35.468 35.746 36.19 36.412 36.856 37.245" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Hipertensión arterial, angor, proﬁ laxis a largo plazo tras IAM, arritmias supraventriculares, taquicardias </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 180.296 124.6995) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.277 1.555 1.833 2.055 2.444 2.888 3.11 3.554 3.832 4.276 4.665 4.887 5.109 5.387 5.831 6.275 6.719 6.941 7.33 7.774 8.052 8.496 8.718 9.162 9.551 9.773 9.995 10.439 10.883 11.327 11.716 11.938 12.382 12.826 13.215 13.437 13.881 14.325 14.603 14.825 15.269 15.491 15.935 16.157 16.435 16.879 17.101 17.323 17.712 18.156 18.545 18.767 19.156 19.378 19.767 20.211 20.489 20.933 21.322 21.766 21.988 22.432 23.099 23.321 23.765 24.209 24.598 24.82 25.264 25.708 25.986 26.43 26.874 27.152 27.596 27.818 28.04 28.484 28.706 29.15 29.594 30.038 30.427 30.705 31.149 31.538 31.76 32.204 32.426 32.648 33.092 33.37 33.814 34.036 34.258 34.48 34.924 35.313 35.535 35.924 36.146 36.59 37.034 37.256 37.478 37.922" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">ventriculares, taquicardias inducidas por digitálicos y catecolaminas durante la anestesia, proﬁ laxis de la </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 180.296 114.4995) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.667 0.889 1.333 1.611 2.055 2.499 2.943 3.165 3.554 3.776 4.22 4.664 4.886 5.108 5.386 5.83 6.497 6.941 7.163 7.607 7.815 8.037 8.259 8.648 9.092 9.536 9.814 10.092 10.536 10.758 10.98 11.424 11.868 12.09 12.534 12.978 13.367 13.589 14.033 14.477 14.921 15.365 15.587 15.976 16.198 16.476 16.92 17.364 17.808 18.03 18.419 18.863 19.141 19.585 19.807 20.251 20.473 20.917 21.361 21.583 22.027 22.471 22.86 23.082 23.526 23.97 24.414" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">migraña y del temblor, control de ansiedad y taquicardia de ansiedad</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 95.256904 99.6296) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.611 1.111 1.611 1.833 2.333" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Acción</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 180.296 99.71545) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.278 1.722 2.166 2.61 3.054 3.276 3.665 3.943" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">Antagonista</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 217.583798 98.98445) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f7" font-size="1px" fill="rgb(43,46,52)"> </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 219.708798 98.98445) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.307" x="0" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">β</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 224.033599 99.71545) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722 1.166 1.444 1.888 2.332 2.776 3.054 3.498 3.72 4.109 4.553 4.775 5.164 5.608 6.275 6.719 7.163 7.441 7.663 7.941 8.163 8.552 8.996 9.218 9.44 9.884 10.328 10.55 10.939 11.383 11.605 12.049 12.438 12.716 12.938 13.327 13.771 13.993 14.215 14.604 14.826 15.27 15.492 15.936 16.325 16.603 16.825 17.214 17.436 17.88 18.324 18.768 18.99 19.379 19.601 20.268 20.712 21.156 21.434 21.656 22.045 22.489 23.156 23.378 24.045 24.489 24.767 24.989 25.378 25.822 26.044 26.266 26.71 26.988 27.266 27.488 27.932 28.321 28.765 29.154 29.598 29.82 30.042 30.598 30.987 31.265 31.487 31.876 32.098 32.542 32.986 33.43" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">-adrenérgico competitivo, no selectivo, sin actividad simpáticomimética intrínseca. Actividad </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 180.296 89.51545) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.667 1.111 1.555 1.999 2.277 2.555 2.999 3.443 3.887 4.109 4.553 4.775 4.997 5.441 5.885 6.163 6.441 6.885 7.329 7.773 7.995 8.439 8.883 9.327 9.771 10.049 10.271 10.66" font-family="g_d0_f5" font-size="1px" fill="rgb(43,46,52)">cronotropa e inotropa negativa</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 87.1882 192.004) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.631 0.993 1.209 1.757 2.196 2.412 2.951 3.167 3.711 4.09 4.602 5.041 5.379 5.595 6.092 6.636 6.821 7.2 7.739 8.093 8.637 9.176 9.688 10.236 10.78 10.992 11.536" font-family="g_d0_f3" font-size="1px" fill="rgb(64,198,192)">Principio activo: propanolol</svg:tspan></svg:text></svg:g></svg:g></svg:g></svg:svg>